Citation
Tolomeo, Francesco, et al. "Cis-Δ9-tetrahydrocannabinolic Acid Occurrence in Cannabis Sativa L." Journal of Pharmaceutical and Biomedical Analysis, vol. 219, 2022, p. 114958.
Tolomeo F, Russo F, Kaczorova D, et al. Cis-Δ9-tetrahydrocannabinolic acid occurrence in Cannabis sativa L. J Pharm Biomed Anal. 2022;219:114958.
Tolomeo, F., Russo, F., Kaczorova, D., Vandelli, M. A., Biagini, G., Laganà, A., Capriotti, A. L., Paris, R., Fulvio, F., Carbone, L., Perrone, E., Gigli, G., Cannazza, G., & Citti, C. (2022). Cis-Δ9-tetrahydrocannabinolic acid occurrence in Cannabis sativa L. Journal of Pharmaceutical and Biomedical Analysis, 219, 114958. https://doi.org/10.1016/j.jpba.2022.114958
Tolomeo F, et al. Cis-Δ9-tetrahydrocannabinolic Acid Occurrence in Cannabis Sativa L. J Pharm Biomed Anal. 2022 Sep 20;219:114958. PubMed PMID: 35930832.
TY - JOUR
T1 - Cis-Δ9-tetrahydrocannabinolic acid occurrence in Cannabis sativa L.
AU - Tolomeo,Francesco,
AU - Russo,Fabiana,
AU - Kaczorova,Dominika,
AU - Vandelli,Maria Angela,
AU - Biagini,Giuseppe,
AU - Laganà,Aldo,
AU - Capriotti,Anna Laura,
AU - Paris,Roberta,
AU - Fulvio,Flavia,
AU - Carbone,Luigi,
AU - Perrone,Elisabetta,
AU - Gigli,Giuseppe,
AU - Cannazza,Giuseppe,
AU - Citti,Cinzia,
Y1 - 2022/07/22/
PY - 2022/05/24/received
PY - 2022/07/06/revised
PY - 2022/07/21/accepted
PY - 2022/8/6/pubmed
PY - 2022/8/17/medline
PY - 2022/8/5/entrez
KW - Cannabinoids
KW - Cannabis sativa
KW - Cis-Δ(9)-tetrahydrocannabinol
KW - Cis-Δ(9)-tetrahydrocannabinolic acid
KW - HPLC-HRMS
SP - 114958
EP - 114958
JF - Journal of pharmaceutical and biomedical analysis
JO - J Pharm Biomed Anal
VL - 219
N2 - Cannabidiolic acid (CBDA) and trans-Δ9-tetrahydrocannabinolic acid (trans-Δ9-THCA) are known to be the major phytocannabinoids in Cannabis sativa L., along with their decarboxylated derivatives cannabidiol (CBD) and trans-Δ9-tetrahydrocannabinol (trans-Δ9-THC). The cis isomer of Δ9-THC has been recently identified, characterized and quantified in several Cannabis sativa varieties, which had been heated (decarboxylated) before the analysis. Since decarboxylation alters the original phytocannabinoids composition of the plant, this work reports the identification and characterization of the carboxylated precursor cis-Δ9-THCA. The compound was also synthesized and used as analytical standard for the development and validation of a liquid chromatography coupled to high resolution mass spectrometry-based method for its quantification in ten Cannabis sativa L. samples from different chemotypes. The highest concentrations of cis-Δ9-THCA were found in CBD-rich varieties, lower levels were observed in cannabigerol (CBG)-rich varieties (chemotype IV) and in those varieties with a balanced level of both CBD and THC (chemotype III), while its levels were not detectable in cannabichromene (CBC)-rich varieties (chemotype VI). The presence of the cis isomer of THC and THCA raises the question on whether to include or not this species in the calculation of the total amount of THC to classify a cannabis variety as a drug-type or a fiber-type (hemp).
SN - 1873-264X
UR - https://www.unboundmedicine.com/medline/citation/35930832/Cis_Δ9_tetrahydrocannabinolic_acid_occurrence_in_Cannabis_sativa_L_
DB - PRIME
DP - Unbound Medicine
ER -